tiprankstipranks
NeuBase Therapeutics Inc (NBSE)
NASDAQ:NBSE

NeuBase Therapeutics (NBSE) Balance Sheet

495 Followers

NeuBase Therapeutics Balance Sheet

NeuBase Therapeutics's total assets for Q4 2023 were $18.62M, a decrease of -16.62% from the previous quarter. NBSE total liabilities were $9.48M for the fiscal quarter, a -14.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Sep 22Sep 21Sep 20Sep 19Sep 18
Total Assets
$ 32.69M$ 64.17M$ 34.44M$ 12.53M$ 249.60K
Total Liabilities
$ 9.50M$ 10.10M$ 3.15M$ 2.50M$ 291.50K
Total Equity Gross Minority
$ 23.19M$ 54.07M$ 31.29M$ 10.03M$ -41.90K
Total Capitalization
$ 23.19M$ 54.07M$ 31.29M$ 10.03M$ 208.10K
Preferred Stock Equity
-----
Capital Lease Obligations
--$ 0.00--
Currency in USD

NeuBase Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis